• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 04/24/15

    • 30-Day SEC Yield1

      -0.09%
    • Total Net Assets

      $818.4M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/18/2015
  • Portfolio Composition (%)
    as of 04/24/15

    • % of Net Assets
    • Stocks

      100.11
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.11
  • Download All HoldingsAll Holdings (%) as of 04/24/15

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    1,109,208
    115,019,32414.05
    Amgen Inc
    AMGN US
    596,545
    100,165,87112.24
    Celgene Corp
    CELG US
    737,005
    87,489,86410.69
    Biogen Idec Inc
    BIIB US
    162,591
    65,314,4317.98
    Regeneron Pharmaceuticals Inc
    REGN US
    92,617
    44,464,4965.43
    Vertex Pharmaceuticals Inc
    VRTX US
    288,554
    38,435,3934.70
    Biomarin Pharmaceutical Inc
    BMRN US
    309,203
    37,190,9374.54
    Alexion Pharmaceuticals Inc
    ALXN US
    197,909
    35,639,4534.35
    Illumina Inc
    ILMN US
    186,024
    35,268,2904.31
    Incyte Corp Ltd
    INCY US
    319,310
    34,274,7354.19
    Medivation Inc
    MDVN US
    250,639
    32,836,2154.01
    Pharmacyclics Inc
    PCYC US
    117,261
    30,088,0003.68
    Alnylam Pharmaceuticals Inc
    ALNY US
    192,150
    22,867,7722.79
    United Therapeutics Corp
    UTHR US
    119,975
    22,398,1332.74
    Qiagen Nv
    QGEN US
    701,601
    17,420,7532.13
    Isis Pharmaceuticals Inc
    ISIS US
    249,497
    16,559,1162.02
    Alkermes Plc
    ALKS US
    234,268
    14,585,5261.78
    Grifols Sa
    GRFS US
    408,436
    13,845,9801.69
    Puma Biotechnology Inc
    PBYI US
    50,500
    11,216,0501.37
    Charles River Laboratories Internationa
    CRL US
    127,288
    9,852,0911.20
    Cepheid Inc
    CPHD US
    160,681
    9,475,3591.16
    Intercept Pharmaceuticals Inc
    ICPT US
    31,337
    8,874,6381.08
    Seattle Genetics Inc
    SGEN US
    167,184
    6,209,2140.76
    Myriad Genetics Inc
    MYGN US
    147,225
    4,945,2880.60
    Mannkind Corp
    MNKD US
    1,002,584
    4,812,4030.59
    Other/Cash
    -891,628-0.11
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.